230 related articles for article (PubMed ID: 11115151)
1. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid.
Baker EA; Leaper DJ
Wound Repair Regen; 2000; 8(5):392-8. PubMed ID: 11115151
[TBL] [Abstract][Full Text] [Related]
2. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
Wysocki AB; Kusakabe AO; Chang S; Tuan TL
Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis in human breast cancer.
Garbett EA; Reed MW; Stephenson TJ; Brown NJ
Mol Pathol; 2000 Apr; 53(2):99-106. PubMed ID: 10889910
[TBL] [Abstract][Full Text] [Related]
4. Determination of endogenous growth factors in human wound fluid: temporal presence and profiles of secretion.
Vogt PM; Lehnhardt M; Wagner D; Jansen V; Krieg M; Steinau HU
Plast Reconstr Surg; 1998 Jul; 102(1):117-23. PubMed ID: 9655416
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
7. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers.
Ladwig GP; Robson MC; Liu R; Kuhn MA; Muir DF; Schultz GS
Wound Repair Regen; 2002; 10(1):26-37. PubMed ID: 11983004
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo.
Mirastschijski U; Impola U; Karsdal MA; Saarialho-Kere U; Agren MS
J Invest Dermatol; 2002 Jan; 118(1):55-64. PubMed ID: 11851876
[TBL] [Abstract][Full Text] [Related]
9. Cytokines, matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome.
Ullbro C; Crossner CG; Nederfors T; Parhar R; Al Mohanna F; Meikle MC; Reynolds JJ; Twetman S
Acta Odontol Scand; 2004 Apr; 62(2):70-4. PubMed ID: 15198385
[TBL] [Abstract][Full Text] [Related]
10. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
[TBL] [Abstract][Full Text] [Related]
11. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis in colorectal cancer.
Garbett EA; Reed MW; Brown NJ
Mol Pathol; 1999 Jun; 52(3):140-5. PubMed ID: 10621835
[TBL] [Abstract][Full Text] [Related]
13. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology.
Baker EA; Leaper DJ
Eur J Cancer; 2003 May; 39(7):981-8. PubMed ID: 12706368
[TBL] [Abstract][Full Text] [Related]
14. Profiles of matrix metalloproteinases and their tissue inhibitors in intraperitoneal drainage fluid: relationship to wound healing.
Baker EA; Leaper DJ
Wound Repair Regen; 2003; 11(4):268-74. PubMed ID: 12846914
[TBL] [Abstract][Full Text] [Related]
15. Implication of MMP-9 and urokinase plasminogen activator (uPA) in the activation of pro-matrix metalloproteinase (MMP)-13.
Kim KS; Lee YA; Choi HM; Yoo MC; Yang HI
Rheumatol Int; 2012 Oct; 32(10):3069-75. PubMed ID: 21913037
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
[TBL] [Abstract][Full Text] [Related]
17. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
[TBL] [Abstract][Full Text] [Related]
19. Growth factor profiles in intraperitoneal drainage fluid following colorectal surgery: relationship to wound healing and surgery.
Baker EA; El Gaddal S; Aitken DG; Leaper DJ
Wound Repair Regen; 2003; 11(4):261-7. PubMed ID: 12846913
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease.
Saito S; Zempo N; Yamashita A; Takenaka H; Fujioka K; Esato K
Vasc Endovascular Surg; 2002; 36(1):1-7. PubMed ID: 12704518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]